Curanex Pharmaceuticals Inc Common Stock (CURX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 8.09M | 11.23M | 14.42M | 711.34K | 696.07K | 666.39K |
| Cash & Short-Term Investments | 4.02M | 4.97M | 5.83M | 108.86K | 198.94K | 374.26K |
| Cash Only | 4.02M | 4.97M | 5.83M | 108.86K | 198.94K | 374.26K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 4.08M | 6.25M | 8.59M | 596.19K | 490.79K | 292.13K |
| Total Non-Current Assets | 317.57K | 352.62K | 60.4K | 75.84K | 90.87K | 49.44K |
| Property, Plant & Equipment | 317.57K | 352.62K | 60.4K | 75.84K | 90.87K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 49.44K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 8.41M | 11.58M | 14.48M | 787.17K | 786.94K | 715.83K |
| Asset Turnover | - | - | - | - | - | - |
| Asset Growth % | 968.86% | - | - | 9.97% | - | - |
| Total Current Liabilities | 128.73K | 137.03K | 185.96K | 75.93K | 192.6K | 600 |
| Accounts Payable | 8.4K | 2.43K | 114.49K | 269 | 126.06K | 0 |
| Days Payables Outstanding | - | -357.82 | - | 382.42 | - | - |
| Short-Term Debt | 107.09K | 122.69K | 61.15K | 70.64K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 21.64K | 14.34K | 10.32K | 0 | 0 | -600 |
| Current Ratio | 62.87x | 81.93x | 77.53x | 9.37x | 3.61x | 1110.65x |
| Quick Ratio | 62.87x | 81.93x | 77.53x | 9.37x | 3.61x | 1110.65x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 203.91K | 224.01K | 0 | 405.82K | 228.56K | 0 |
| Long-Term Debt | 203.91K | 224.01K | 0 | 400K | 200K | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 5.82K | 28.56K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 332.64K | 361.04K | 185.96K | 481.74K | 421.16K | 601 |
| Total Debt | 311K | 346.7K | 61.15K | 476.45K | 291.18K | 0 |
| Net Debt | -3.71M | -4.63M | -5.77M | 367.59K | 92.23K | -374.26K |
| Debt / Equity | 0.04x | 0.03x | 0.00x | 1.56x | 0.80x | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | - | 66.97x | -232.27x | -18.52x | -100.46x | - |
| Total Equity | 8.08M | 11.22M | 14.29M | 305.43K | 365.78K | 715.23K |
| Equity Growth % | 2108.63% | - | - | -57.3% | - | - |
| Book Value per Share | 0.29 | 0.44 | 0.56 | 0.01 | 0.01 | 0.02 |
| Total Shareholders' Equity | 8.08M | 11.22M | 14.29M | 305.43K | 365.78K | 715.23K |
| Common Stock | 2.84K | 2.83K | 2.83K | 2.4K | 2.4K | 4K |
| Retained Earnings | -8M | -4.85M | -1.77M | -820.38K | -760.03K | -385.35K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |